SupplySide West Podcast 57: Assessing Inflammation Claims for Dietary Supplements

In this podcast interview, Ashish Talati--a partner in Chicago with the law firm Amin Talati Upadhye LLP--weighs in on the sometimes-gray area between acceptable structure/function claims and prohibited disease claims when marketing dietary supplements related to inflammation.

In this podcast interview with Josh Long, INSIDER's legal editor, Ashish Talati—a partner in Chicago with the law firm Amin Talati Upadhye LLP— weighs in on the sometimes-gray area between acceptable structure/function claims and prohibited disease claims when marketing dietary supplements related to inflammation. The regulatory lawyer also discusses the FTC's authority to monitor the advertising of dietary supplements to ensure claims are backed by adequate science.

Talati will be speaking on Friday, Sept. 29, during a workshop at SupplySide West in Las Vegas. The workshop “Addressing Inflammation Naturally … and Legally,” will explore how inflammation works in the body, the state of research on anti-inflammatory ingredients, and making claims that will toe the line and avoid the wrath of federal regulators.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish